Abbott Targets Teva Over Latest Simcor ANDA

By Leigh Kamping-Carder · August 16, 2011, 1:18 PM EDT

Abbott Laboratories on Friday continued its bid to protect the market for cholesterol drug Simcor, filing another patent infringement suit in Delaware against generic-drug maker Teva Pharmaceutical Industries Ltd....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Abbott Laboratories et al v. Teva Pharmaceuticals USA Inc. et al

Case Number

Court

Delaware

Nature of Suit

Patent

Date Filed

August 12, 2011

Recent Articles By Leigh

August 19, 2011
Schering Says Judge Missed Key Facts In Sales Rep OT Suit
July 25, 2011
Lupin, Medicis Reach Deal Over Generic Solodyn
July 21, 2011
Fed. Circ. Says Teva Can't Block Cenestin Generic
July 15, 2011
Shire Targets Mylan In Latest Suit Over Generic Vyvanse
July 15, 2011
Hospital, Workers Must Address Union Status: 1st Circ.
July 11, 2011
Pfizer Targets Apotex In Fight To Block Generic Lyrica
June 30, 2011
ViiV Goes After Lupin Over HIV Drug ANDA
June 28, 2011
Medtronic Sues Edwards Over Heart Valve Patents
June 15, 2011
Apotex Can't Dodge Schering Suit Over Nasonex IP
June 14, 2011
Alcon Sues Watson To Block Pataday Generic